期刊文献+

当前血脂异常的药物治疗的再认识 被引量:4

下载PDF
导出
摘要 动脉粥样硬化(Atherosclerosis,AS)致血栓形成所导致的心脑血管疾病目前居全球死因的首位,但是我国血脂异常知识的知晓率、血脂异常治疗的达标率均明显偏低。文章对当前药物治疗优缺点略做综述。1血脂异常与动脉粥样硬化的关系血脂是指血浆中的胆固醇、三酰甘油(Triglyceide,TG)和类脂如磷脂等的总称。
作者 刘卫清 陈宇
出处 《吉林医学》 CAS 2013年第8期1516-1519,共4页 Jilin Medical Journal
  • 相关文献

参考文献18

  • 1Williams KJ,Tabas I.The respone-to-retention hypotheseis of earlyatherognesis[J].Aeterioscler Thromb Vasc boil,1995,15(3):551.
  • 2Franceschini G.Epodemiologic evidence for high-denestinyliporotin cholesterol as a risk factor for coronany artery disease[J].AMJ Coronany,2001,18(1):9.
  • 3The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量:126
  • 4李瑜.他汀类药物的多效性在心血管疾病中应用进展[J].心血管进展,2010,30(1):127.
  • 5Vogt A,Kassner U.Prolonged-release nicotinic acid for themanagement of dyslipidemia an update including results from theNAUTILUS study[J].Vascul health risk Manag,2007,3(4):467.
  • 6关静,霍艳艳.烟酸类药物研究进展[J].沈阳医学院院报,2011,13(1):110.
  • 7陈国良,刘立伟,谢爽,刘红,刘玉清,李一石.高密度脂蛋白胆固醇代谢及其对冠心病影响的研究进展[J].心血管病学进展,2010,31(3):360-363. 被引量:58
  • 8于晖,高岩,娄可佳,刘晓宁,惠汝太.对血浆Lp(a)致动脉硬化作用的再评价—9540正常人群及4055病例对照结果分析[J].中国分子心脏病学杂志,2005,5(3):542-546. 被引量:6
  • 9Carey VJ,Bishop L,Laranjo N,et al.Contribution of high plasmatriglycerides and low high-density lipoprotein cholesterol to residualrisk of coronary heart diease after establishment of low-densitylipoprotein cholesterol control[J].Am J Cardiol,2010,106(6):757.
  • 10Dullaart RP.Increased coronary heart disease risk determinedby high-density lipoprotine cholesterol and C-readctive protinemodulation by variation in the CETP gene[J].Arterioscler thromb VascBiol,2010,30(8):1502.

二级参考文献35

  • 1杨人勋,徐伟,李祖兴.脂蛋白(a)与动脉粥样硬化[J].心血管病学进展,1994,15(4):221-224. 被引量:18
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 3武阳丰,赵冬,周北凡,王薇,李贤,刘静,李莹,孙佳艺,赵连成,吴兆苏,诸骏仁.中国成人血脂异常诊断和危险分层方案的研究[J].中华心血管病杂志,2007,35(5):428-433. 被引量:176
  • 4Franceschini G.Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease[J].Am J Cardiol,2001,88:9-13.
  • 5Johansen O,Abdelnoor M,Brekke M,et al.Predictors of restenosis after coronary angioplasty.A study on demographic and metabolic variables[J].Scand Cardiovasc J,2001,35:86-91.
  • 6Barter PJ,Kastelein JJ.Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease[J].J Am Coll Cardiol,2006,47:492-499.
  • 7Schwartz CC,VandenBroek JM,Cooper PS,et al.Lipoprotein cholesteryl ester production,transfer,and output in vivo in humans[J].J Lipid Res,2004,45:1594-1607.
  • 8Florentin M,Liberopoulos EN,Wierzbicki AS,et al.Multiple actions of high-density lipoprotein[J].Curr Opin Cardiol,2008,23:370-378.
  • 9Barter PJ,Nicholls S,Fogelman AM,et al.Antiinflammatory properties of HDL[J].Circ Res,2004,95:764-772.
  • 10Aviram M,Rosenblat M.Paraoxonases 1,2,and 3,oxidative stress,and macrophage foam cell formation during atherosclerosis development[J].Free Radic Biol Med,2004,37:1304-1316.

共引文献187

同被引文献47

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部